| __timestamp | Exelixis, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 2043000 | 4167274 |
| Thursday, January 1, 2015 | 3895000 | 5247851 |
| Friday, January 1, 2016 | 6552000 | 4925118 |
| Sunday, January 1, 2017 | 15066000 | 14930297 |
| Monday, January 1, 2018 | 26348000 | 25371768 |
| Tuesday, January 1, 2019 | 33097000 | 23921274 |
| Wednesday, January 1, 2020 | 36272000 | 25338236 |
| Friday, January 1, 2021 | 52873000 | 20182966 |
| Saturday, January 1, 2022 | 57909000 | 17562000 |
| Sunday, January 1, 2023 | 72547000 | 25212000 |
Unleashing insights
In the dynamic world of biotechnology, cost management is crucial for sustaining growth and innovation. This chart compares the cost of revenue for Exelixis, Inc. and Pharming Group N.V. from 2014 to 2023. Exelixis, Inc. has seen a remarkable increase in its cost of revenue, growing by over 3,400% from 2014 to 2023. This surge reflects the company's expanding operations and investment in research and development. In contrast, Pharming Group N.V. experienced a more modest growth of around 500% during the same period, indicating a steadier approach to scaling its operations. The year 2017 marked a pivotal point where both companies had nearly identical costs, highlighting a brief convergence in their financial strategies. As of 2023, Exelixis, Inc.'s cost of revenue is nearly three times that of Pharming Group N.V., showcasing its aggressive growth trajectory.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Biogen Inc. vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Incyte Corporation and Exelixis, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Bio-Techne Corporation vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.
Exelixis, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Exelixis, Inc. vs Geron Corporation
Exelixis, Inc. vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses